US President Donald Trump’s son-in-law, Jared Kushner, has been questioned by special counsel Robert Mueller’s team of investigators about former national security adviser Michael Flynn, a person familiar with the investigation said on Wednesday.
The person said the questioning of Kushner earlier this month took about 90 minutes or less and was aimed in part at establishing whether Kushner had any information on Flynn that might be exculpatory.
The person said multiple White House witnesses have been asked about their knowledge of Flynn, who was forced to resign from the White House in February after officials concluded he had misled them about his contacts with the then-Russian ambassador.
The confirmation of Kushner’s interview came as prosecutors working for Mueller postponed grand jury testimony related to Flynn’s private business dealings.
The reason for the postponement was not immediately clear, but it comes one week after attorneys for Flynn alerted Trump’s legal team that they could no longer share information about the case.
That discussion between lawyers was widely seen as a possible indication that Flynn was moving to cooperate with Mueller’s investigation or attempting to negotiate a deal for himself.
An attorney for Flynn, Robert Kelner, did not immediately respond to e-mail and telephone messages on Wednesday afternoon.
Peter Carr, a spokesman for Mueller, declined comment.
Kushner’s attorney, Abbe Lowell, said in a statement: “Mr Kushner has voluntarily cooperated with all relevant inquiries and will continue to do so.”
The details of Kushner’s questioning and the postponement of the grand jury testimony were confirmed by people familiar with Mueller’s investigation.
They spoke on condition of anonymity because they were not authorized to publicly discuss the ongoing investigation.
Both developments were first reported by CNN.
The grand testimony that had been scheduled for the coming days related to Flynn’s firm, Flynn Intel Group, its work with a public relations firm and interactions with congressional staff, one of the people said.
Mueller and the FBI have been interested in hearing from employees at the public relations firm, SGR LLC, because of the firm’s work with Flynn Intel Group. SGR LLC, which does business as Sphere Consulting, did public relations work on a film Flynn Intel Group was working on about Turkish cleric Fethullah Gulen, who lives in exile in Pennsylvania.
The film was never completed.
Mueller was appointed by the US Department of Justice in May to oversee an investigation into potential coordination between Russia and the Trump campaign to influence the outcome of last year’s presidential election.
The investigation, which produced its first criminal charges last month against three former Trump campaign officials, incorporated an earlier FBI inquiry into Flynn’s lobbying and investigative research work on behalf of a Turkish businessman.
Flynn’s firm was paid US$530,000 for the work.
Sphere employees have cooperated for months with Mueller’s investigation, including by turning over documents requested by investigators and sitting for voluntary interviews.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS